Gemcitabine-Associated Pneumocystis carinii Pneumonia

Author： Weber J.   Hackelsberger N.   Thalmaier U.   Schepp W.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.1, 2000-07, pp. : 65-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pneumocystis Carinii Pneumonia in Adolescents

By Rudy B.J.  

Pediatric Drugs, Vol. 2, Iss. 2, 2000-03 ,pp. : 133-138

Adis International

Access to resources Recommend Favorite

Pneumocystis carinii Pneumonia in an Immunocompetent Host

By Giamarellos-Bourboulis E.J.  

Clinical Drug Investigation, Vol. 23, Iss. 2, 2003-01 ,pp. : 135-137

Adis International

Access to resources Recommend Favorite

Anti-Pneumocystis carinii pneumonia activity of dicationic carbazoles

By Patrick D.   Boykin D.   Wilson W.   Tanious F.   Spychala J.   Bender B.   Hall J.   Dykstra C.   Ohemeng K.   Tidwell R.  

European Journal of Medicinal Chemistry, Vol. 32, Iss. 10, 1997-10 ,pp. : 781-793

Elsevier

Access to resources Recommend Favorite

Temozolomide: Pneumocystis carinii pneumonia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1181, 2007-01 ,pp. : 35-36

Adis International

Access to resources Recommend Favorite

Prednisone/rituximab: Pneumocystis carinii pneumonia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1261, 2009-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite